Condition: Moderate-to-severe Atopic Dermatitis · Sponsor: TRex Bio, Inc.
This Phase 1a/1b randomized, double-blind, placebo-controlled study evaluates the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of subcutaneously (SC) administered TRB-061 in healthy adults and patients with moderate-to-severe atopic dermatitis (AD). The number of dosing cohorts may be increased or decreased in Part 1 (SAD) or Part 2 (MAD). Part 1 (SAD): Healthy participants receiving single doses of TRB-061 or placebo. Part 2 (MAD): Healthy participants receiving multiple doses (3 doses over 8 weeks) of TRB-061 or placebo. Part 3 (Phase 1b): Participants with moderate-to-severe AD receiving repeated doses (4 doses over 12 weeks) of TRB-061 or placebo.
This description comes directly from the study's public registry record.
Study Director · +1 (650) 567-5582 · clinicaltrials@trex.bio
Always discuss trial participation with your own doctor first.
| Paratus Clinical Research - Canberra Trial Clinic | Belconnen, Australian Capital Territory, Australia | Recruiting |
| Paratus Clinical Brisbane Pty Ltd | Albion, Brisbane, Australia | Recruiting |
| Paratus Clinical Research Western Sydney | Blacktown, New South Wales, Australia | Recruiting |
| Paratus Clinical Research Central Coast | Kanwal, New South Wales, Australia | Recruiting |
| Cornerstone Centre for Clinical Research | Coorparoo, Queensland, Australia | Recruiting |
| CMAX Clinical Research Pty Ltd | Adelaide, South Australia, Australia | Active Not Recruiting |
| Paratus Clinical Research Melbourne | Melbourne, Victoria, Australia | Recruiting |
| Momentum Clinical Research Pukekohe | Pukekohe, Auckland, New Zealand | Recruiting |
| Momentum Clinical Research Dunedin | Dunedin, Otago, New Zealand | Recruiting |
| Pacific Clinical Research Network-Tasman | Nelson, Tasman District, New Zealand | Recruiting |
| Clinical Trials New Zealand Ltd | Hamilton, Waikato Region, New Zealand | Recruiting |
| Medical Research Institute of New Zealand | Newtown, Wellington Region, New Zealand | Recruiting |
+ 3 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.